105 related articles for article (PubMed ID: 13678696)
1. Anticoagulant potential of an antibody against factor VII.
Chu AJ; Mathews ST
J Surg Res; 2003 Sep; 114(1):37-41. PubMed ID: 13678696
[TBL] [Abstract][Full Text] [Related]
2. Novel anticoagulant activity of polyamino acid offsets bacterial endotoxin-induced extrinsic hypercoagulation: downregulation of monocytic tissue factor-dependent FVII activation.
Chu AJ; Rauci M; Nwobi OI; Mathews ST; Beydoun S
J Cardiovasc Pharmacol; 2003 Oct; 42(4):477-83. PubMed ID: 14508232
[TBL] [Abstract][Full Text] [Related]
3. Novel anticoagulant activity of polybrene: inhibition of monocytic tissue factor hypercoagulation following bacterial endotoxin induction.
Chu AJ; Rauci M; Nwobi OI; Mathews ST; Beydoun S
Blood Coagul Fibrinolysis; 2002 Mar; 13(2):123-8. PubMed ID: 11914654
[TBL] [Abstract][Full Text] [Related]
4. Polycations selectively blocking tissue factor-dependent FVII activation: collective in vitro anticoagulation studies.
Chu AJ
Inflamm Allergy Drug Targets; 2011 Feb; 10(1):13-8. PubMed ID: 21184651
[TBL] [Abstract][Full Text] [Related]
5. Blockade by ruthenium red of tissue factor-initiated coagulation.
Chu AJ; Wang ZG; Nwobi OI; Beydoun S
Br J Pharmacol; 2001 Jul; 133(5):659-64. PubMed ID: 11429389
[TBL] [Abstract][Full Text] [Related]
6. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
Chu AJ; Wang ZG; Fox MJ
Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
[TBL] [Abstract][Full Text] [Related]
7. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
8. Novel anticoagulant polyethylenimine: inhibition of thrombin-catalyzed fibrin formation.
Chu AJ; Beydoun S; Mathews ST; Hoang J
Arch Biochem Biophys; 2003 Jul; 415(1):101-8. PubMed ID: 12801518
[TBL] [Abstract][Full Text] [Related]
9. IV. Anticoagulant activity of compound 48/80: inhibition of factor VII activation in leukemia THP-1 monocytes.
Chu AJ; Wang ZG; Raphael UO
J Cardiovasc Pharmacol; 2000 Nov; 36(5):649-55. PubMed ID: 11065226
[TBL] [Abstract][Full Text] [Related]
10. Protamine inhibits tissue factor-initiated extrinsic coagulation.
Chu AJ; Wang ZG; Raicu M; Beydoun S; Ramos N
Br J Haematol; 2001 Nov; 115(2):392-9. PubMed ID: 11703341
[TBL] [Abstract][Full Text] [Related]
11. A high affinity monoclonal antibody recognizing the light chain of human coagulating factor VII.
Sarial S; Asadi F; Jeddi-Tehrani M; Hadavi R; Bayat AA; Mahmoudian J; Taghizadeh-Jahed M; Shokri F; Rabbani H
Hybridoma (Larchmt); 2012 Dec; 31(6):443-8. PubMed ID: 23244324
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial peptide buforin I inhibits tissue factor-initiated coagulation.
Chu AJ; Chen BM; Lin H; Beydoun S
Arch Biochem Biophys; 2001 Aug; 392(1):3-7. PubMed ID: 11469787
[TBL] [Abstract][Full Text] [Related]
13. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex.
Rønning HF; Risøen UC; Orning L; Sletten K; Sakariassen KS
Thromb Res; 1996 Oct; 84(2):73-81. PubMed ID: 8897697
[TBL] [Abstract][Full Text] [Related]
15. A novel anti-tissue factor monoclonal antibody with anticoagulant potency derived from synthesized multiple antigenic peptide through blocking FX combination with TF.
Peng ZC; Cai X; Zhang YG; Kong DS; Guo HS; Liang W; Tang QQ; Song HY; Ma D
Thromb Res; 2007; 121(1):85-93. PubMed ID: 17573098
[TBL] [Abstract][Full Text] [Related]
16. Influence of warfarin therapy on activated factor VII clotting activity.
Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
[TBL] [Abstract][Full Text] [Related]
17. Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304-->Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor.
Matsushita T; Kojima T; Emi N; Takahashi I; Saito H
J Biol Chem; 1994 Mar; 269(10):7355-63. PubMed ID: 8125953
[TBL] [Abstract][Full Text] [Related]
18. Purification and properties of human melanoma cell tissue factor.
Siddiqui FA; Amirkhosravi A; Amaya M; Desai H; Meyer T; Francis JL
Clin Appl Thromb Hemost; 2001 Oct; 7(4):289-95. PubMed ID: 11697711
[TBL] [Abstract][Full Text] [Related]
19. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.
Toso R; Pinotti M; High KA; Pollak ES; Bernardi F
Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672
[TBL] [Abstract][Full Text] [Related]
20. Interspecies exchange mutagenesis of the first epidermal growth factor-like domain of human factor VII.
Williamson V; Pyke A; Sridhara S; Kelley RF; Blajchman MA; Clarke BJ
J Thromb Haemost; 2005 Jun; 3(6):1250-6. PubMed ID: 15892860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
